SOL S.p.A. Overview
Pro stress-test →SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company operates a dual-focus model with a home-care segment that generates the majority of revenue and sells medicinal gases including oxygen, nitrogen, nitrous oxide, and carbon dioxide, alongside a technical gases segment that sells gas-based products to the energy, agricultural, food, metalworking, glass, and electronics industries.
Strategic Profile
Pro stress-test →As an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases with significant involvement in the home care medical business through provision of home care services such as oxygen therapy, mechanical ventilation, and diagnosis and care of obstructive sleep apnea syndrome, SOL has established a diversified healthcare-industrial hybrid model. The company leverages digital health solutions including InfoHealth SOLution, a web platform that controls plans, coordinates, and manages all activities carried out within healthcare facilities, positioning it competitively in both traditional industrial gases and modern healthcare services.
Competitive Landscape
Pro stress-test →SOL competes in the technical and medical gases market with a broad portfolio spanning oxygen, nitrogen, argon, hydrogen, and specialty gases. Primary competitors include larger multinational gas companies like Linde and Air Liquide, as well as regional European specialists. SOL differentiates through its integrated home care business model and proprietary healthcare management software, particularly strong in Southern European markets. The company maintains competitive pricing in commodity segments while commanding premium positioning in specialized healthcare services.
Industry Context
SOL S.p.A. operates in Specialty Chemicals / Industrial Gases.
Key facts
Founded: 1927 · Headquarters: Milan, Italy · Employees: 7,291 · Revenue: €1.64B